Innova Biosciences introduces Biotin Check&Go! Kit
Kit for confirming successful antibody-biotin conjugation.
Innova Biosciences has launched the Biotin Check&Go! Kit, which sits alongside its recently launched Conjugate Check&Go! Kit and is the company’s second lateral flow product specific to antibody labeling.
The new kit allows researchers to confirm with a quick and easy test whether an antibody has been successfully conjugated to biotin, ensuring that no materials or time are wasted using unsuccessful antibody-biotin conjugates in their downstream application.
The traditional method of biotinylation detection is the HABA assay, which is time consuming, requires large quantities of sample, and often yields variable results. Innova’s Biotin Check&Go! Kit comprises a simple immunochromatography test that requires minute quantities of antibody conjugate and is complete within 10 minutes. The new kit is compatible with Innova’s Lightning-Link® Biotinylation Kit, which allows easy and rapid conjugation of biotin to antibodies in less than 20 minutes, as well as other biotin labeling technologies available commercially.
Nick Gee, CEO and CSO at Innova Biosciences, commented: “The Lightning-Link Biotinylation Kit is one of our most popular products, and the new Biotin Check&Go! Kit has been developed following discussions with customers about their need for a quick and reliable qualitative test for biotinylation. At Innova Biosciences we are continually working with customers to ensure that the products we develop support their research, and help to increase productivity.”
Innova’s recently launched Conjugate Check&Go! Kit enables scientists to demonstrate successful conjugation of antibodies with colored labels such as fluorescent dyes and proteins, gold nanoparticles and latex beads. The Company’s conjugation technologies include Lightning-Link for antibody & protein labeling, InnovaCoat® GOLD nanoparticles and Latex beads, and Thunder-Link PLUS for oligonucleotide conjugation.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance